The recent wave of layoffs and financial troubles at CRISPR-focused startups should not tarnish the promise of CRISPR.

From STAT’s Matthew Herper: Pfizer said this morning that it would stop development of danuglipron, its experimental oral GLP ...

In a nutshell Cambridge researchers developed a new DNA classification system that reveals hidden patterns in cancer, ...

Genomics Market Liquid Biopsy Liquid biopsy is a non-invasive method for detecting cancer by analyzing blood samples for genetic mutations ...

A review paper published last year in European Journal of Medicinal Chemistry characterized Myc as the “oncogene from ...

HPGDS enzyme plays key role in resistance of immunotherapy in various cancers  Up to 65% of patients with melanoma do not ...

What's been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.

Cancer Stem Cell Market Cancer stem cells (CSCs) are a distinct subset of tumor cells with stem-like properties, including self-renewal and ...

David R. Walt, a professor at Harvard Medical School and Boston’s Brigham and Women’s Hospital, lost hundreds of thousands in research funding from the Trump administration last week — just two months ...

Through an international joint research, a Korean research team developed the world's first pre-stage lesion (pre-cancer lesion) that implements the world's first pre-stage head and neck cancer lesion ...

During the 47th session of the King Faisal Prize on April 14, exceptional accomplishments in the fields of cellular engineering and nanotechnology were honored. Professor Michel Sadelain was awarded ...

A class action lawsuit was filed against Intellia Therapeutics Inc. (NTLA) by Levi & Korsinsky on February 11, 2025. The ...